En esta página
INM InMed Pharmaceuticals Inc. - Common Shares
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Sep 9, 2026
$1,33
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,58mínimo 52 semanas
$2,50máximo 52 semanas
Capitalización Bursátil (MRQ)
$7M
P/E
-0.4
BPA
$-3.12
Ingresos
$5M
tus insignias
Rango 52S
$1–$2
Calificación del Analista
SELL
Precio Objetivo
·
P/E
-0.4
ROE
-235.6%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
INM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.33
Capitalización Bursátil (MRQ)
$7M
P/E
-0.4
BPA
$-3.12
Ingresos
$5M
ROE
-235.6%
Rango 52S
$1–$3
INM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 14 de noviembre de 2024 | 1-for-20 | Inversa |
| 7 de septiembre de 2022 | 1-for-25 | Inversa |
| 6 de julio de 2020 | 1-for-33 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$5M2022-06-30 → 2025-06-30
BPA$-3.122021-06-30 → 2026-06-30
Flujo de caja libre·2021-06-30 → 2024-06-30
Margen neto·2024-06-30 → 2024-06-30
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | INM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.4promedio 5A ≈-2.8 | ≈-2.8 | · | · | |
| P/S | 1.6 | · | · | · | |
| P/C (MRQ) | 6.6 | · | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -0.8 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 6.6promedio 5A ≈8.5 | ≈8.5 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | INM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -135.0% | · | · | · | |
| ROE | -235.6% | · | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | INM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.4 | · | · | · | |
| Quick Ratio (Ratio Rápido) | 1.1 | · | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | INM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 7.5%promedio 5A ≈99.4% | ≈99.4% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 65.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | INM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue / Employee (Ingresos / Empleado) | ≈$823.8K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-152.6%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de septiembre de 2025 | $-1.94 | — | — | |
| 30 de junio de 2024 | $-0.19 | — | — | |
| 31 de marzo de 2024 | $-0.76 | — | — | |
| 30 de junio de 2022 | $-280.60 | $-111.10 | -152.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | · | $5M | $5M | $4M | $1M | |
| Cost of Revenue | · | $3M | $3M | $3M | $545.9K | |
| Gross Profit | · | $2M | $1M | $1M | $543.5K | |
| R&D Expense | $3M | $3M | $3M | $4M | $7M | |
| SG&A Expense | $7M | $5M | $6M | $6M | $7M | |
| Operating Expenses | $12M | $8M | $9M | $10M | $18M | |
| Operating Income | · | · | · | $-8M | $-19M | |
| Interest Income | $245.0K | $155.9K | $527.9K | $492.4K | $96.1K | |
| Other Non-op | · | · | $527.9K | $492.4K | $-1M | |
| Pretax Income | $-11M | $-9M | $-8M | $-8M | $-19M | |
| Income Tax | · | · | $7.1K | $13.1K | · | |
| Net Income | $-13M | $-8M | $-8M | $-8M | $-19M | |
| EPS (Basic) | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 | |
| EPS (Diluted) | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 | |
| Shares (Basic) | 4,163,598 | 975,895 | 381,053 | 2,448,458 | 560,829 | |
| Shares (Diluted) | 4,163,598 | 975,895 | 381,053 | 2,448,458 | 560,829 | |
| EBITDA | $205.3K | · | $219.6K | · | · |
Balance general
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $11M | $7M | $9M | $6M | |
| Short-term Investments | $39.7K | $43.4K | $43.1K | $44.4K | $44.8K | |
| Receivables | · | $465.1K | $352.8K | $260.4K | $88.0K | |
| Inventory | · | $961.2K | $1M | $2M | $2M | |
| Prepaid Expense | $241.3K | $319.5K | $477.7K | $498.0K | $797.2K | |
| Current Assets | $3M | $13M | $9M | $11M | $10M | |
| PP&E (Net) | $221.0K | $992.2K | $1M | $723.4K | $904.3K | |
| PP&E (Gross) | $810.7K | $2M | $3M | $2M | $1M | |
| Accum. Depreciation | $373.3K | $1M | $1M | $925.3K | $516.5K | |
| Intangibles | · | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $132.3K | $100.0K | $100.0K | $104.9K | $176.6K | |
| Total Assets | $3M | $16M | $12M | $14M | $13M | |
| Accounts Payable | $2M | $1M | $2M | · | $2M | |
| Accrued Liabilities | · | · | $256.5K | $357.7K | · | |
| Current Liabilities | $2M | $2M | $2M | $2M | $3M | |
| Capital Leases | · | $305.8K | $644.9K | $16.0K | $389.5K | |
| Total Liabilities | $2M | $2M | $3M | $2M | $4M | |
| Common Stock | $94M | $91M | $83M | $78M | $71M | |
| Paid-in Capital | · | · | · | $36M | $32M | |
| Retained Earnings | $-130M | $-117M | $-109M | $-101M | $-93M | |
| AOCI | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | |
| Stockholders' Equity | $1M | $13M | $9M | $12M | $9M | |
| Liabilities + Equity | $3M | $16M | $12M | $14M | $13M | |
| Shares Outstanding | 5,339,436 | 2,002,186 | 445,908 | 166,370 | 650,667 |
Flujo de Efectivo
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| D&A | $205.3K | $212.8K | $219.6K | $202.2K | $185.7K | |
| Stock-based Comp | $106.9K | $119.3K | $137.7K | $278.2K | $697.9K | |
| Amort. of Intangibles | $162.6K | $162.6K | $171.9K | $159.2K | $159.2K | |
| Other Non-cash | $4M | · | $332.4K | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-7M | $-7M | $-16M | |
| CapEx | · | · | $9.3K | $160.0K | $39.1K | |
| Investing Cash Flow | · | · | $-9.3K | $-661.8K | $-673.0K | |
| Stock Issued | · | · | · | $12M | $17M | |
| Financing Cash Flow | $94.5K | $12M | $5M | $11M | $15M | |
| Net Change in Cash | · | · | $-2M | $3M | $-1M | |
| Free Cash Flow | · | · | $-7M | · | · |
Rentabilidad
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Gross Margin | · | · | 23.9% | · | · | |
| Net Margin | · | · | -166.9% | · | · | |
| Pretax Margin | · | · | -166.8% | · | · | |
| EBITDA Margin | · | · | 4.8% | · | · | |
| ROA | -135.0% | · | -59.2% | · | · | |
| ROE | -235.6% | · | -75.6% | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | 4.4 | · | · | |
| Quick Ratio | 1.1 | · | 3.5 | · | · |
Eficiencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.4 | · | · | |
| Inventory Turnover | · | · | 2.4 | · | · | |
| Receivables Turnover | · | · | 15.0 | · | · |
Por Acción
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Book Value / Share | $0.20 | · | $1.03 | · | · | |
| Revenue / Share | · | · | $0.60 | · | · | |
| Cash Flow / Share | $-2.08 | · | $-0.92 | · | · | |
| Cash / Share | $0.41 | · | $0.74 | · | · | |
| EPS (TTM) | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 |
Tasas de Crecimiento
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | 7.5% | 11.2% | 279.6% | · | |
| Revenue CAGR 3Y | · | 65.5% | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | $5M | $4M | $1M | |
| Net Income TTM | $-13M | $-8M | $-8M | $-8M | $-19M | |
| Market Cap | $8M | · | $47M | · | · | |
| P/E | -0.5 | -0.4 | -0.3 | -5.7 | -7.1 | |
| P/S | 1.8 | · | 10.3 | · | · | |
| P/B | 7.7 | · | 5.2 | · | · | |
| P / Tangible Book | 7.7 | 0.6 | 6.4 | 6.1 | 21.9 | |
| P / Cash Flow | -1.0 | · | -6.8 | · | · | |
| P / FCF | · | · | -6.8 | · | · | |
| Earnings Yield | -201.3% | -257.2% | -378.6% | -17.5% | -14.1% |
Estado de resultados
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $820.2K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $901.9K | $2M | $1M | $469.8K | $320.8K | |
| Cost of Revenue | · | · | $636.0K | $717.0K | $728.1K | $1M | $650.8K | $771.2K | $817.0K | $883.1K | $916.1K | $880.6K | $1M | $841.4K | $338.6K | $235.0K | |
| Gross Profit | · | · | $184.2K | $403.2K | $576.7K | $175.6K | $460.9K | $493.4K | $466.1K | $289.5K | $324.1K | $21.2K | $2M | $192.5K | $131.2K | $-491.0K | |
| R&D Expense | $793.6K | $1M | $630.6K | $581.6K | $800.5K | $425.4K | $895.2K | $700.1K | $658.9K | $656.8K | $609.8K | $1M | $623.7K | $878.3K | $851.4K | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $618.4K | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | |
| Operating Expenses | $4M | $3M | $2M | $2M | $1M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | |
| Operating Income | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | $-2M | $-2M | $-4M | |
| Interest Income | $29.1K | $47.8K | $74.4K | $93.8K | $51.7K | $16.6K | $30.5K | $57.1K | $103.6K | $121.5K | $166.8K | $136.0K | $148.6K | $155.5K | $115.8K | $72.6K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | $136.0K | · | · | · | $65.8K | |
| Pretax Income | $-5M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-336.6K | $-2M | $-2M | $-4M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.8K | |
| Net Income | $-6M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-338.4K | $-2M | $-2M | $-4M | |
| EPS (Basic) | $-1.44 | $-0.73 | $-0.51 | $-0.44 | $-0.07 | $-1.94 | $-3.64 | $-2.71 | $2.39 | $-3.58 | $-3.71 | $-15.24 | $2.32 | $-0.60 | $-0.91 | $-4.06 | |
| EPS (Diluted) | $-1.44 | $-0.73 | $-0.51 | $-0.44 | $-0.07 | $-1.94 | $-3.64 | $-2.71 | $2.39 | $-3.58 | $-3.71 | $-15.24 | $2.32 | $-0.60 | $-0.91 | $-4.06 | |
| Shares (Basic) | · | 4,048,209 | 3,954,549 | 3,954,549 | · | 1,095,973 | 706,546 | 620,127 | · | 480,649 | 398,673 | 166,410 | · | 3,328,191 | 2,300,526 | 865,619 | |
| Shares (Diluted) | · | 4,048,209 | 3,954,549 | 3,954,549 | · | 1,095,973 | 706,546 | 620,127 | · | 480,649 | 398,673 | 166,410 | · | 3,328,191 | 2,300,526 | 865,619 | |
| EBITDA | · | · | · | $53.2K | · | · | · | $54.6K | · | · | · | $-2M | · | $-2M | $-2M | $-3M |
Balance general
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $7M | $9M | $11M | $5M | $3M | $6M | $7M | $8M | $10M | $7M | $9M | $10M | $11M | $9M | |
| Short-term Investments | $39.7K | $41.6K | $42.7K | $42.9K | $43.4K | $40.6K | $40.8K | $43.2K | $43.1K | $43.1K | $44.5K | $42.9K | $44.4K | $43.1K | $43.1K | $42.1K | |
| Receivables | · | · | $183.0K | $343.5K | $465.1K | $367.8K | $262.6K | $284.7K | $352.8K | $207.7K | $372.9K | $165.8K | $260.4K | $170.3K | $81.6K | $15.2K | |
| Inventory | · | · | $947.9K | $890.8K | $961.2K | $814.0K | $1M | $1M | $1M | $1M | $744.8K | $1M | $2M | $1M | $2M | $2M | |
| Prepaid Expense | $241.3K | $617.2K | $660.3K | $191.8K | $319.5K | $507.9K | $644.0K | $148.9K | $477.7K | $1M | $1M | $215.0K | $498.0K | $695.2K | $826.9K | $356.7K | |
| Current Assets | $3M | $7M | $9M | $11M | $13M | $6M | $5M | $7M | $9M | $10M | $12M | $8M | $11M | $12M | $14M | $12M | |
| PP&E (Net) | $221.0K | $642.9K | $764.3K | $881.5K | $992.2K | $1M | $1M | $1M | $1M | $1M | $1M | $615.1K | $723.4K | $753.2K | $703.9K | $802.4K | |
| PP&E (Gross) | $810.7K | · | · | · | $2M | $2M | $2M | $2M | $3M | $3M | · | $2M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | $373.3K | · | · | · | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $925.3K | $819.3K | $716.8K | $618.4K | |
| Intangibles | · | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $132.3K | $104.4K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $101.8K | $104.9K | $147.5K | $171.1K | $171.1K | |
| Total Assets | $3M | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M | $13M | $15M | $11M | $14M | $15M | $17M | $15M | |
| Accounts Payable | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2.0K | $2M | $1M | $1M | $1M | · | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $85.5K | · | $167.5K | $100.4K | · | $357.7K | · | · | · | |
| Current Liabilities | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $3M | |
| Capital Leases | · | $30.8K | $123.8K | $215.5K | $305.8K | $419.3K | $529.2K | $633.8K | $644.9K | $725.2K | $802.8K | · | $16.0K | $72.8K | $183.9K | $294.3K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | $2M | $2M | $3M | $4M | |
| Common Stock | $94M | $93M | $92M | $92M | $91M | $87M | $85M | $84M | $83M | $81M | $80M | $78M | $78M | $78M | $75M | $73M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | $38M | · | · | $36M | $38M | $35M | |
| Retained Earnings | $-130M | $-124M | $-121M | $-119M | $-117M | $-115M | $-113M | $-111M | $-109M | $-107M | $-105M | $-104M | $-101M | $-101M | $-99M | $-97M | |
| AOCI | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | |
| Stockholders' Equity | $1M | $7M | $10M | $12M | $13M | $7M | $6M | $8M | $9M | $11M | $13M | $10M | $12M | $12M | $14M | $11M | |
| Liabilities + Equity | $3M | $9M | $11M | $13M | $16M | $9M | $9M | $10M | $12M | $13M | $15M | $11M | $14M | $15M | $17M | $15M | |
| Shares Outstanding | 5,339,436 | 3,314,063 | 2,804,186 | 2,604,186 | 2,002,186 | 1,207,186 | 724,152 | 667,013 | 445,908 | 6,344,970 | 5,667,970 | 3,328,191 | 3,328,191 | 3,328,191 | 1,589,992 | 908,766 |
Flujo de Efectivo
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $48.4K | $50.5K | $53.2K | $53.2K | $52.8K | $52.3K | $53.2K | $54.6K | $54.8K | $54.8K | $55.2K | $54.8K | $53.5K | $50.7K | $49.0K | $49.0K | |
| Stock-based Comp | $22.6K | $38.8K | $25.3K | $20.2K | $26.7K | $40.5K | $23.2K | $29.0K | $39.0K | $55.3K | $18.3K | $25.2K | $40.5K | $50.4K | $70.6K | $116.7K | |
| Amort. of Intangibles | $39.6K | $41.0K | $41.0K | $41.0K | $39.6K | $41.0K | $41.0K | $41.0K | $48.9K | $41.0K | $41.0K | $41.0K | $37.1K | $40.1K | $41.0K | $41.0K | |
| Other Non-cash | · | · | · | $45.9K | · | · | · | $-232.5K | · | · | · | $282.6K | · | · | · | $1M | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-1M | $-2M | $-2M | $-2M | $-657.9K | $-2M | $-3M | $-2M | |
| CapEx | · | · | · | · | · | · | · | · | $0 | $2 | · | · | $31.8K | · | · | · | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | $0 | $-2 | · | · | $-33.6K | $-128.2K | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $174 | $6M | $6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Financing Cash Flow | $-1 | $231.7K | $0 | $-137.2K | $8M | $3M | $338.5K | $838.2K | $176 | $0 | · | · | $0 | $-63.7K | $5M | $5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $-2M | · | · | $-691.5K | $-2M | $2M | $3M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.8K |
Rentabilidad
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 22.5% | 36.0% | · | 13.9% | 41.5% | 39.0% | · | 24.7% | 26.1% | 2.4% | · | 18.6% | 27.9% | -153.1% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -281.3% | · | -193.2% | -447.2% | -1094.2% | |
| Net Margin | · | · | -247.3% | -154.2% | · | -168.1% | -231.6% | -132.7% | · | -146.9% | -119.2% | -281.3% | · | -193.2% | -447.2% | -1094.2% | |
| Pretax Margin | · | · | -247.3% | -154.2% | · | -168.1% | -231.6% | -132.7% | · | -146.9% | -119.2% | -281.3% | · | -193.1% | -446.6% | -1092.1% | |
| EBITDA Margin | · | · | · | 4.8% | · | · | · | 4.3% | · | · | · | -275.2% | · | -193.2% | -447.2% | -1079.0% | |
| ROA | · | -32.2% | -20.6% | -14.5% | · | -18.7% | -21.7% | -15.7% | · | -12.3% | -9.2% | -19.9% | · | -13.2% | -11.6% | -22.0% | |
| ROE | · | -42.6% | -25.7% | -17.3% | · | -23.4% | -27.2% | -18.7% | · | -14.7% | -10.9% | -24.6% | · | -17.2% | -14.7% | -26.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 3.1 | 5.9 | 6.9 | · | 3.5 | 3.1 | 5.1 | · | 6.6 | 7.0 | 6.2 | · | 5.2 | 5.8 | 3.5 | |
| Quick Ratio | · | 2.4 | 4.9 | 6.2 | · | 2.8 | 2.1 | 4.1 | · | 5.1 | 5.9 | 5.2 | · | 4.3 | 4.8 | 2.9 |
Eficiencia
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | 0.6 | 0.7 | · | 1.1 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.5 | · | 0.6 | 0.3 | 0.3 | |
| Receivables Turnover | · | · | 3.7 | 3.6 | · | 4.4 | 3.5 | 5.6 | · | 6.2 | 5.5 | 10.0 | · | 8.6 | 7.1 | 21.4 |
Por Acción
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.08 | $3.42 | $4.45 | · | $5.82 | $8.54 | $12.59 | · | $1.75 | $2.25 | $2.88 | · | $3.72 | $9.02 | $12.11 | |
| Revenue / Share | · | · | $0.21 | $0.28 | · | $1.15 | $1.57 | $2.04 | · | $0.12 | $0.16 | $0.27 | · | $0.31 | $0.20 | $0.37 | |
| Cash Flow / Share | · | · | · | $-0.41 | · | · | · | $-2.95 | · | · | · | $-0.65 | · | · | · | $-2.61 | |
| Cash / Share | · | $1.56 | $2.48 | $3.58 | · | $3.88 | $4.72 | $8.37 | · | $1.20 | $1.68 | $2.02 | · | $2.89 | $7.20 | $10.29 | |
| EPS (TTM) | · | $-1.75 | $-2.96 | $-6.09 | · | $-5.90 | $-7.54 | $-7.61 | · | $-20.21 | $-17.23 | $-14.43 | · | $-18.70 | $-24.24 | $-31.06 |
Valoración (TTM)
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $6M | $5M | $5M | · | $2M | $2M | $1M | |
| Net Income TTM | · | $-9M | $-8M | $-8M | · | $-8M | $-8M | $-7M | · | $-6M | $-6M | $-7M | · | $-15M | $-17M | $-19M | |
| Market Cap | · | $2M | $3M | $6M | · | $2M | $3M | $3M | · | $46M | $47M | $47M | · | $72M | $64M | $120M | |
| P/E | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.6 | -0.6 | · | -0.4 | -0.5 | -1.0 | · | -1.2 | -1.7 | -4.2 | |
| P/S | · | 0.5 | 0.7 | 1.2 | · | 0.5 | 0.7 | 0.6 | · | 8.2 | 8.6 | 9.9 | · | 30.7 | 39.8 | 85.0 | |
| P/B | · | 0.3 | 0.3 | 0.5 | · | 0.4 | 0.6 | 0.4 | · | 4.2 | 3.7 | 4.9 | · | 5.8 | 4.5 | 10.9 | |
| P / Tangible Book | · | 0.4 | 0.4 | 0.6 | · | 0.5 | 0.8 | 0.5 | · | 5.0 | 4.3 | 6.1 | · | 6.9 | 5.2 | 13.4 | |
| P / Cash Flow | · | · | · | -3.5 | · | · | · | -1.7 | · | · | · | -21.4 | · | · | · | -53.1 | |
| Earnings Yield | · | -271.3% | -279.2% | -278.1% | · | -285.0% | -159.1% | -160.5% | · | -277.6% | -207.1% | -103.1% | · | -86.6% | -60.0% | -23.5% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Ingresos | · | $5M | $5M | $4M | $1M |
| Margen Bruto % | · | · | 23.9% | · | · |
| Beneficio neto | $-13M | $-8M | $-8M | $-8M | $-19M |
| EPS Diluido | $-3.12 | $-8.36 | $-20.14 | $-3.25 | $-33.17 |
| Métrica | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Ratio corriente | 1.4 | · | 4.4 | · | · |
| Ratio Rápido | 1.1 | · | 3.5 | · | · |
| Métrica | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | · | $-7M | · | · |
Propietarios institucionales (13F) 21 declarantes · $4.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
21
Valor en tenencia
$4.2M
Nuevas posiciones
13
Posiciones cerradas
2
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 13 (+9 vs trimestre anterior) | 2 (0 vs trimestre anterior) | 0 (-2 vs trimestre anterior) | 3 (+3 vs trimestre anterior) | +2.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | $1 240 000 | 800 000 | 29,65% | Acciones |
| Vivo Capital, LLC | $1 237 484 | 798 377 | 29,59% | Acciones |
| Squadron Capital Management LLC | $503 750 | 325 000 | 12,04% | Acciones |
| Ikarian Capital, LLC | $379 788 | 245 025 | 9,08% | Acciones |
| Ursa Fund Management, LLC | $194 990 | 125 800 | 4,66% | Acciones |
| MONTANOVA CAPITAL, LLC | $155 000 | 100 000 | 3,71% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $115 078 | 74 244 | 2,75% | Acciones |
| SABBY MANAGEMENT, LLC | $69 704 | 44 970 | 1,67% | Acciones |
| JANE STREET GROUP, LLC | $66 771 | 43 078 | 1,60% | Acciones |
| Venrock Adviser, LLC | $50 662 | 32 685 | 1,21% | Acciones |
| CITADEL ADVISORS LLC | $40 430 | 26 084 | 0,97% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $38 750 | 25 000 | 0,93% | Acciones |
| Scientech Research LLC | $23 965 | 15 461 | 0,57% | Acciones |
| Crestwood Advisors Group, LLC | $23 095 | 14 900 | 0,55% | Acciones |
| TWO SIGMA SECURITIES, LLC | $16 965 | 10 945 | 0,41% | Acciones |
| Stratos Wealth Partners, LTD. | $16 678 | 10 760 | 0,40% | Acciones |
| Private Wealth Management Group, LLC | $7 750 | 5 000 | 0,19% | Acciones |
| Banque Cantonale Vaudoise | $1 000 | 6 | 0,02% | Acciones |
| SBI Securities Co., Ltd. | $465 | 300 | 0,01% | Acciones |
| Federation des caisses Desjardins du Quebec | $4 | 2 | 0,00% | Acciones |
| AllSquare Wealth Management LLC | $2 | 1 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., Vivo Opportunity Cayman, LLC | 10 de junio de 2026 | 21,70% | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 18 insiders · 8 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Eric A Adams | President & CEO | 19 de diciembre de 2025 A | 43 959 | 0 | 0 | $0 |
| Netta Jagpal | Chief Financial Officer | 19 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Jonathan Tegge | Interim CFO | 23 de diciembre de 2023 A | · | 0 | 0 | $0 |
| Bruce Colwill | CFO | 24 de enero de 2022 P | 11 515 | 0 | 0 | $0 |
| Michael Woudenberg | Chief Operating Officer | 19 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Shane Aaron Johnson | Sr VP & General Manager | 19 de diciembre de 2025 A | 304 595 | 0 | 0 | $0 |
| Eric C Hsu | Sr. VP, Pre-Clinical Res/Dev | 19 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Sarah Li | VP Accounting & Controller | 16 de diciembre de 2022 A | · | 0 | 0 | $0 |
| John Steven Bathery | Consejero | 19 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Nicole Lemerond | Consejero | 19 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Andrew Hull | Consejero | 19 de diciembre de 2025 A | 38 258 | 0 | 0 | $0 |
| Neil A Klompas | Consejero | 19 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Bryan T Baldasare | Consejero | 20 de diciembre de 2024 A | · | 0 | 0 | $0 |
| Janet P Grove | Consejero | 20 de diciembre de 2024 A | · | 0 | 0 | $0 |
| Adam D. Cutler | Consejero | 24 de enero de 2022 H | · | 0 | 0 | $0 |
| William J Garner | Consejero | 24 de enero de 2022 H | · | 0 | 0 | $0 |
| Catherine Sazdanoff | Consejero | 29 de diciembre de 2021 A | · | 0 | 0 | $0 |
| Alexandra Diane Janet Mancini | · | 31 de julio de 2024 S | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
INM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 8 analistas
VENTA
0 0,0%
Compra fuerte
0 0,0%
Compra
3 37,5%
Mantener
4 50,0%
Venta
1 12,5%
Venta fuerte
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| INM | $8M | -0.5 | 7.5% | · | -235.6% | · |
| LEXX | $17M | -1.3 | 52.0% | -1686.0% | -215.9% | 99.6% |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-K presentada el Sep 9, 2026